Table 1 Clinical characteristics of the patients
WHO mucostis grade | p value | ||
|---|---|---|---|
Grade 1–2 | Grade 3–4 | ||
n (%) | n (%) | ||
Age | |||
Mean | 51.1 | 46.2 | 0.328 |
Range | 28-80 | 32-67 | |
Gender | |||
Male | 8 (53.3%) | 6 (60.0%) | 1.000 |
Female | 7 (46.7%) | 4 (40.0%) | |
Treatment regime | |||
Radiotherapy | 5 (33.3%) | 2 (20.0%) | 0.659 |
Chemoradiotherapy | 10 (66.7%) | 8 (80.0%) | |
Tumor staging | |||
T1 | 1 (13.3%) | 1 (10.0%) | 0.737 |
T2 | 5 (33.3%) | 5 (50.0%) | |
T3 | 3 (20.0%) | 3 (30.0%) | |
T4 | 2 (13.3%) | 1 (10.0%) | |
Tx | 4 (20.0%) | 0 (0.0%) | |
Tumor types | |||
Nasopharyngeal carcinoma | 9 (60.0%) | 10 (100%) | 0.330 |
Nasal cavity NHL | 2 (13.3%) | 0 (0.0%) | |
Nasal cavity carcinoma | 2 (13.3%) | 0 (0.0%) | |
Parotid gland carcinoma | 1 (6.7%) | 0 (0.0%) | |
External auditory canal carcinoma | 1 (6.7%) | 0 (0.0%) | |